It’s just $46,000 a year

Back in the hospital; pain, bloody stools.
Report: “Inflammation throughout; scope
unsafe to advance.”
Desperately pushing steroids to ward off
surgical management.

Medication list shows infliximab — last
infusion one year prior.
It induced remission, but something
changed.
Immune cascade again overflowing;
colonic mucosa now eroding.

Drug failure?
No.
Health insurance lost, cost prohibitive.
System failure.

John Gaumnitz, MD

Department of Internal Medicine

John is a resident in Internal Medicine and an aspiring gastroenterologist. He is interested in exploring/highlighting the complex social factors associated with medication adherence in chronic diseases. He enjoys the simple pleasures of a warm blanket, a quiet morning with coffee, and the occasional golden weekend.

Voices from the Housestaff:
2023, "It's just $46,000 a year" View more for John Gaumnitz, MD